Lyme disease is a bacterial infection caused by a spirochete (spiral-shaped bacteria) called Borrelia burgdorferi (Bb). The bacterium is named after the person who discovered it, Dr. Willy Burgdorfer. Lyme disease is named after the Connecticut town of Lyme where it was first recognized in the United States in 1977. The first record of a condition associated with Lyme disease dates back to the 1880’s.

Both humans and animals can be infected with the Bb organism through the bite of an infected tick. Over 100 strains of the bacterium that cause Lyme disease have been identified in the United States. Lyme infection is usually transmitted by, though not limited to, three species of tick:

The black-legged tick (ixodes scapularis) on the East Coast and in the Midwest (commonly known as the deer tick). The western black-legged tick (ixodes pacificus) in the Western U.S. (also commonly known as the deer tick). The lone star tick (amblyomma americanum), located within a rectangle encompassing Texas, Florida, Rhode Island, and Iowa.

Lyme disease is also a global problem. There are reports that 300 bacterial strains of the Bb organism have been identified throughout the world. Cases of Lyme disease have been reported in North and South America, Europe, Asia, Africa and Australia.

Symptoms

Early signs of Lyme disease include flu-like symptoms (headache, fever, muscle aches, joint pain and fatigue) and a Lyme rash. Most symptoms show up days or weeks and occasionally months following infection.

The Lyme rash is referred to as erythema migrans or EM. It is important to remember that the rash may not show up at all, or it may appear too light in color to be noticed. The rash can be shaped like a bulls-eye, it can be smooth or bumpy, it may or may not feel warm, and there can be multiple rashes that can appear at the site of the tick bite or elsewhere on the body.

Once the infection becomes established, symptoms of Lyme disease vary but may include pain in muscles and joints, fatigue, swollen glands, fever, upset stomach, headache, forgetfulness, sleep disorders, depression, and sensitivity to light and sound, to name a few.

Lyme Confusion

The medical community is often perplexed by the highly individual and complex nature of Lyme disease. Some people experience Lyme disease as a minor illness that appears to be easily treated with antibiotic therapy without any longlasting complications. Others are not as fortunate.

When Lyme disease goes undetected, undiagnosed and untreated for months or years following infection, the bacteria can spread to the nervous system, the heart and other organs, tendons and joints. This late-stage infection can result in a wide variety of physical, emotional, and mental or cognitive symptoms. The late-stage list of symptoms is long and can include arthritis, heart abnormalities, Bell’s palsy (paralysis of one or both sides of the face) and severe cognitive or mental dysfunction including memory loss, confusion, psychiatric problems, etc.

Lyme disease is often referred to as the Great Pretender because the symptoms of Lyme disease can so closely mimic the symptoms of other diseases. Although no official numbers exist on this subject, Lyme patients have been misdiagnosed with chronic fatigue syndrome, fibromyalgia, multiple sclerosis, menopause, depression, Alzheimer’s disease, and Lou Gehrig’s disease. Other patients have failed to receive any kind of definitive diagnosis long after the presentation of symptoms.

Early Detection Is Paramount

Nearly all Lyme medical specialists agree that early detection and treatment of Lyme disease significantly improves the chance of a full recovery. Although not proven, some experts believe that there is up to a six to eight week window of opportunity following infection when treating the disease with antibiotic therapy can result in a high cure rate and lessen the chance of chronic, long-term problems.

It has been reported that it takes an average of 22 months and seven doctors for the average Lyme patient to be diagnosed with a Bb infection. This follows the fact that many people infected with Lyme disease do not remember being bitten by a tick, which can further delay treatment. The inability to diagnose and treat Lyme disease in a timely fashion may be adding to the number of patients who suffer from chronic symptoms.

It is estimated by some that as many as 20 percent of Lyme patients suffer from persistent and chronic symptoms. This figure may be too low. Obviously, more research would be helpful. However, what is clear is that the importance of early diagnosis and treatment cannot be over-emphasized.

Treatment

Lyme disease is a bacterial infection and like other bacterial infections it is treated with antibiotics. Antibiotics are administered orally, with intramuscular (IM) injections, or intravenously (IV) through the veins. Physicians often prescribe combinations of antibiotics to take advantage of the diverse ways that individual antibiotics affect the Bb organism.

Physicians not only prescribe more than one oral antibiotic at a time, but they combine oral antibiotics with IM or IV antibiotics. This shotgun (or multiple) approach to antibiotic therapy is used in hopes of affecting the Bb organism in as many ways as possible.

Just as no two Lyme patients appear to be affected by Lyme bacteria in the same way, a patient’s response to antibiotic therapy is highly individual, too. The individual nature of an antibiotic’s effect on a patient is believed to be due in part to the theory that different strains of the bacteria react differently to each antibiotic. Other factors may include the duration of infection, the amount of time between the onset of symptoms and treatment, and the location of the Bb organism in the body. Also, co-infections or the transmittal of more than one infectious disease, can occur from a single tick bite. This can make diagnosis and treatment more difficult still.

Female doctor removing a tick with tweezers from hand of patient. Encephalitis, borreliosis and lyme disease.

Co-infections

Co-infections may include more than one strain of the Bb organism and may include the tick-borne disorders of babesiosis and/or ehrlichiosis. Babesiosis and ehrlichiosis are also bacterial infections that present Lyme-like symptoms. However, treatment is often handled in a different manner from Lyme disease. Babesiosis requires a treatment program that is altogether different from antibiotic therapy for Lyme disease. Not all antibiotics that are used to treat Lyme disease are effective in treating ehrlichiosis.

Information on Lyme disease and co-infections is relatively new. It is highly recommended that those suffering from long-term, chronic symptoms be tested for babesiosis and ehrlichiosis if they have not already done so. Obviously, patients who have recently been diagnosed with Lyme disease should make sure that they are tested for co-infections, too.

It is our experience that many Lyme patients have not been tested for babesiosis and ehrlichiosis. This is a situation in which many patients, and health care professionals alike, have not yet adopted the most current medical practices. Testing is a Problem

The diagnosis of Lyme disease remains clinically based—that is, a diagnosis based primarily on symptoms alone—because, unfortunately, there is no test available that is 100 percent accurate to rule out or confirm the infection. False positive results and false negative results are common. Accordingly, the patient’s entire clinical picture is taken into account when diagnosing and treating Lyme disease.

We can better understand the lack of proper testing for Lyme disease by identifying the fact that there is not a common test that allows health care professionals to accurately determine if Lyme bacteria are present in the body. Amazingly, the lack of a common test also means that medical science cannot precisely determine whether someone is cured. This leads to contradictory treatment protocols and results in treatment guidelines that are more guesswork than many patients prefer, and less exact than many physicians and health insurance companies are comfortable with.

Science in general, and medical science in particular, prefers absolute and unmistakable testing, data and conclusions on which to base treatment protocols (or guidelines). Lyme disease was not recognized in the United States until 1977. Scientific research is lagging and there is much we don’t know. Based on current scientific knowledge, the diagnosis and treatment of Lyme disease cannot be absolute and unequivocal. Instead—and no matter how unsettling this may be—until research catches up, the treatment of Lyme disease cannot be anything but subjective, open to question, individualized, and often complex.

Current Testing

The most common and current tests that are available today are limited to determining if antibodies to the Bb organism exist. The body creates antibodies after being exposed to the Bb organism. Lyme antibodies can remain in a person’s body long after the Lyme organism has been eliminated. This means that a positive Lyme antibody test does not accurately indicate if active Lyme bacteria continue to be present in the body.

The ELISA and Western Blot tests are the most common tests currently used to confirm the presence of Bb antibodies. Current testing protocols were proposed in 1994 at the Second National Conference on Serological Diagnosis of Lyme Disease. A two-step process was established. The first step calls for a test such as the ELISA to be conducted. If positive, a Western-blot test is done in hopes of confirming that Lyme antibodies exist. However, even if Lyme antibodies exist, it does not mean that the patient has Lyme disease.

The Lyme Urine Antigen Test (LUAT) is a newer antibody test that is being used more frequently by Lyme physicians. As of this writing the Food and Drug Administration (FDA) has not approved the LUAT test for use in the clinical diagnosis of Lyme disease.

Further complicating matters is the fact that antibody tests can confuse Lyme antibodies with antibodies created by other complications in the body, including antibodies created in reaction to bacteria other than the Bb organism. This means that most of the current tests are not completely accurate. It also means that it is not uncommon to receive false positive and false negative results when using the ELISA, Western Blot or LUAT tests.

In other words, a negative test result cannot guarantee that Lyme antibodies do not exist. Conversely, a positive test result cannot guarantee that you actually have Lyme antibodies in your system. In both cases, accurate positive antibody test results do not mean that you even have active Lyme bacteria in your system. As we stated earlier, a positive antibody test result does not mean that you have Lyme disease.

The PCR Test

Two final notes on testing. First, some physicians use a Polymerase Chain

Reaction (PCR) test to confirm that Lyme bacteria are present in the body. The PCR test is relatively new. It is designed to confirm that Lyme bacteria DNA are present. A positive PCR test almost always guarantees that you have Lyme disease, depending upon the accuracy of the lab that performed the work. However, because it can be difficult to isolate the Bb organism’s DNA, a negative PCR test does not eliminate a Lyme disease diagnosis. The PCR test is usually more expensive than the ELISA, Western Blot or LUAT antibody tests.

The second note on testing has to do with the fact that test results often vary depending upon which lab performs the test. Some Lyme patients assume that testing for Lyme disease—and the test results—are uniform, standard and guaranteed. They are not. When we combine this fact with what we have already learned about testing for Lyme disease, it becomes obvious that the diagnosis of Lyme disease is not an exact science.

Jarisch-Herxheimer Reaction

A proper understanding of the Jarisch-Herxheimer reaction has helped Lyme specialists better manage the diagnosis and treatment of Lyme disease. This is especially true in light of inadequate testing. A Herxheimer reaction occurs in Lyme patients after they begin antibiotic therapy. It is important to note that a Herxheimer reaction is not a common reaction that is associated with most other diseases or with other viral, bacterial or fungal infections. A Jarisch-Herxheimer reaction is limited to a few specific bacterial infections such as syphilis and Lyme disease. It is interesting that syphilis and Lyme disease stem from spirochetal or spiral-shaped bacteria.

A Herxheimer reaction occurs when symptoms recur, flare up or become exaggerated. Some call it a healing crisis, while others describe it as getting worse before you get better. Lyme patients refer to this reaction as a herx, or say that they are herxing.

A Herxheimer reaction usually occurs within days to weeks of starting antibiotic therapy. When antibiotics directly kill Lyme bacteria or work with the body’s immune system to kill the organism, toxins are released that cause either “direct reactions or indirect actions through stimulation of the immune system.”⁵ In simpler terms, a Herxheimer reaction occurs when Lyme bacteria are killed off more quickly than the body’s organs (kidneys and liver) are able to process them. This increases the number of toxins in the blood stream. The higher the toxin count, the more severe the symptoms the patient experiences.

Without accurate testing, the Herxheimer reaction is often used as a clinical diagnostic tool to help determine the presence of the Bb organism. It can also be used to confirm the effectiveness of specific antibiotics or combinations of antibiotics. Specifically, some health care professionals believe that a Herxheimer reaction can confirm that the Bb organism is present in the body by the fact that a bacteria die-off is causing the herx. Thus, for the frontline physician, the Herxheimer reaction can assist in the clinical diagnosis by unofficially confirming the presence of the Bb organism.

The Politics of Lyme Disease

This leads us to a pivotal and controversial issue that divides the medical community concerning the diagnosis and treatment of Lyme disease.

Some health care professionals are more tradition-bound and conservative in their approach to Lyme disease. They have adopted protocols for treating Lyme that don’t go much beyond relatively short-term antibiotic therapy. This group believes that in almost all cases, one or two courses of oral antibiotics are all that are required to eradicate the bacteria. They believe that persistent, chronic Lyme symptoms are not the result of an ongoing infection—of active Lyme bacteria in the body—but rather, are probably the result of a dysfunctional auto-immune system response or some other process occurring in the body.

Others—especially those physicians who remain on the frontline of the long-term treatment of Lyme patients—believe that Lyme bacteria are not always eliminated by short-term courses of antibiotics. They believe that this is especially true if the disease went undiagnosed and untreated for months or years following infection.

Further, this latter group believes that the Bb organism can persist through months and even years of antibiotic therapy, depending upon a wide range of individual factors relating to the patient and to the strain(s) of bacteria. The survival characteristics of the bacteria themselves also play a crucial role in Lyme bacteria’s persistent longevity.

Survival Tactics?

Research has shown that the Bb organism can use the body’s own protein to encapsulate itself. ⁶ This is also described as the Lyme bacterium shifting to a dormant or sleeping state. The reason that the organism undergoes this change is not fully understood. Some believe that this is a survival tactic because it may not be possible for our immune system to destroy the bacterium when it is in this state. Also, antibiotics may have little or no effect on the Bb organism when it is encapsulated and dormant.

Research also shows that the Lyme bacterium appears to be able to enter certain types of human cells. This ability may also be considered a survival tactic because it results in the bacterium evading some or all antibiotics as well as the body’s immune system.

Alternative Health Care

Antibiotics are the main tools that medical science uses to combat Lyme bacteria. However, it is our experience that many Lyme patients invest time, money and energy into exploring non-antibiotic, alternative health measures to treat Lyme symptoms. These can vary from taking supplements to visiting alternative health care practitioners. This area is much too large and diverse to explore in this article. Suffice it to say that Lyme disease is a highly individual ailment. Not only are symptoms experienced individually (and differently) by each Lyme patient, but every form of treatment (including antibiotic therapy) works differently for each individual. We do not know why this is so.

Most chronic Lyme patients have learned through experience that ultimately, it is their responsibility to manage their own health care. Many Lyme patients have made a conscious decision to explore alternative health care practices along with exploring conventional medical practices with their physician(s). We encourage responsible curiosity in both areas.

Antibiotics

Because antibiotics are the main tools that are used to fight Lyme disease, we can gain a better understanding of Lyme disease if we better understand how antibiotics affect the Bb organism. For a better understanding of how antibiotics work it helps to understand the mechanism of action they employ. Generally speaking, antibiotics fall into two categories:

o Bactericidal—An agent that directly destroys bacteria. o Bacteriostatic — An agent that arrests or hinders the growth of bacteria.

Antibiotics that are bactericidal (for example, think… homicidal) can directly attack the cell wall of the bacteria. This causes a rupture and the death of the organism follows. Antibiotics from the penicillin family of antibiotics are usually bactericidal, unless concentrations fall too low.

Antibiotics that are bacteriostatic (for example, think… manipulative) do not directly attack bacteria. Instead, they interfere with the ability of the organism to reproduce. Without the ability to reproduce the bacteria can eventually die out. Bacteriostatic antibiotics include tetracyclines such as Doxycycline. It is important to remember that most antibiotics can be both bactericidal and bacteriostatic, depending upon the amount or concentration of the antibiotic in the body. More clearly still, most bacteriostatic antibiotics can become bactericidal if the concentrations are strong enough.

One of the main points to understand about bacteriostatic antibiotics is that they are usually effective in debilitating bacteria only when bacteria reproduce. This is significant for two reasons. First, it is believed that dormant Lyme bacteria don’t reproduce, which diminishes bacteriostatic antibiotic’s effectiveness in fighting Lyme disease. Second, Lyme bacteria have a long reproductive cycle. A mature Lyme bacterium reproduces once every 7 hours or so. This reproductive cycle may vary from species to species. In comparison, some species of the strep throat bacterium reproduce once every 20 to 30 minutes. It is not known how many reproductive cycles are needed before all Lyme bacteria are debilitated by antibiotics.

However, according to Karen Vanderhoof-Forschner in her book, Everything You Need To Know About Lyme Disease, the strep bacterium is normally treated with antibiotics through 480 reproductive cycles⁷. She says that if we were to treat Lyme disease through the same number of cycles it would take somewhere between 5 to 30 months of antibiotic therapy. If this is true, it is significant that some physicians follow a protocol for treating Lyme disease that allows just two to six weeks of antibiotic therapy. Based on the above scenario this may be inadequate.

If either of the above examples are true, this may mean that physicians who are acting in good faith by using conservative treatment protocols may actually be prolonging and thus complicating Lyme infection in their patients. However, much of this theory is speculative. Obviously, more research is needed.

Devastating Survival Tactic?

We have discussed how it is believed that Lyme bacteria primarily use two methods of invading the body’s immune system and evading certain antibiotics. If the theory behind this belief is true then the two methods of evasion used by the Bb organism include:

1. The Lyme bacterium encapsulates itself in the body’s protein (the cell wall membrane) and lies dormant for undetermined periods of time.
2. The Lyme bacterium hides by entering the body’s cells.

In both cases the bacteria may be able to evade the body’s specialized defensive mechanisms, along with evading the offensive mechanisms of antibiotics. However, the final piece of this puzzle has to be considered a genetic marvel no matter how devastating it is to Lyme patients. When Lyme bacteria shift from a dormant to an active state they can resume reproduction and effectively re-seed the body. This reestablishes the Lyme infection. If it is true that dormant bacteria can wake up and re-seed the body, this particularly devastating maneuver indicates that short-term courses of antibiotics may be ineffective in eradicating Lyme bacteria from the body.

Mechanism of Action

Antibiotics and other anti-infective agents (anything that counteracts infection) can kill different kinds of bacteria. However, an antibiotic’s mechanisms of action—or how they kill bacteria—varies depending upon the type of antibiotic used. Because the mechanism of action varies among antibiotics and antiinfective agents, a specific antibiotic—or specific combinations of antibiotics—may be a better choice than other combinations when attempting to eradicate the Bb organism.

For example, Zithromax (azithromycin) is known to have higher tissue concentration levels when compared to the blood concentration levels it usually attains. Zithromax is also known to have an ability to penetrate some cells in our body more effectively than other antibiotics. This may have an added benefit when treating the Bb organism because we believe that Lyme bacteria have the ability to enter certain types of our cells.

Later, we will discuss in more detail why specific combinations of antibiotics work better than other combinations when treating Lyme disease. At this point we simply want to identify how the treatment of Lyme disease becomes a complex task with a myriad of options and protocols that are dependent upon an everwidening circle of circumstances. As we stated earlier, until research catches up, the treatment of Lyme disease cannot be anything but subjective, open to question, individualized, and often complex.

Between a Rock and a Hard Place

While the medical community waits for research to help our understanding of how we can better detect the Lyme organism, frontline Lyme physicians are left with the question, “What is the best way to treat chronic Lyme symptoms?” Many of these physicians emphatically state that their experience indicates that the effects of long-term antibiotic therapy are a lesser consequence compared to what life would be like for their patients if they were left untreated and the bacteria left unchecked in their system.

The Lyme controversy is fueled by the fact that current Lyme testing cannot definitively prove or disprove the presence of active Lyme bacteria in a person’s body. Not having an accurate Lyme test forces physicians to rely on less than exact medical science. The alternative is to rely on no treatment at all. Thus, the controversy shows no sign of abating as long as testing methods that conclusively determine the existence of active Lyme infection remain unavailable to the frontline physician.

A final comment on Lyme disease. The medical community will continue to be perplexed and divided about Lyme disease until proper testing options become available. This has serious consequences for Lyme patients who are often left to fend for themselves in a confusing and contradictory medical environment. In an ideal world, people who are in various stages of illness—many of whom have been incapacitated by their Lyme symptoms—should not be put in this situation by a medical system whose purpose is to help, not frustrate their recovery.

Hyperbaric Oxygen (HBO) Therapy

HBO therapy is a medical treatment that uses the administration of 100 percent oxygen at controlled pressure (greater than sea level) for a prescribed amount of time—usually 60 to 90 minutes. HBO therapy is commonly used to treat conditions such as burns and difficult or stubborn healing wounds.

HBO therapy increases the amount of oxygen in the body, which in turn causes several physiological changes that can result in accelerated healing. The basis for these changes is the fact that HBO therapy increases the amount of oxygen in the blood by up to 2000 percent, depending on the treatment depth. This, in turn, dramatically increases the amount of oxygen at the cellular level and creates other physiological changes. These changes can be extremely complex. One scientific research study indicates that Lyme bacteria are microaerophilic, or debilitated in high oxygen environments.

In the case of Lyme disease, William Fife,

Ph. D., a Hyperbaric Medicine specialist at Texas A & M University (now retired), established the protocols for HBO treatment in his Texas A & M research project, to be discussed later. Dr. Fife’s Lyme disease protocol calls for HBO therapy to be administered at 2.36 ATA   ^{William Fife, Ph.D.}

(Atmospheres absolute), or equivalent to a depth of 45 feet below sea level. Each treatment lasts one hour and two treatments are prescribed each day, five days per week.

The total number of treatments given in each case varies. It is common to administer 30 to 60 treatments in the first phase of treatment. The question of further HBO therapy is then resolved after the patient’s condition is reevaluated. However, many believe that if the patient has been impacted by the first phase of HBO therapy, such as by experiencing a Herxheimer reaction (this can help to confirm Lyme bacteria die-off), then a break of three to six weeks should be taken followed by another 30 to 60 HBO treatments. A physician can prescribe more sets of HBO therapy based on the patient’s individual evaluation.

Risks?

HBO therapy is a medical procedure and like any other medical procedure there can be risks. However, when HBO therapy is administered by trained health care individuals these risks are minimal. (As with any medical procedure, the evaluation and understanding of the current health status of the patient is of prime importance.)

Minor ear discomfort is the most common inconvenience related to HBO therapy. It is helpful to remember that the initial stage of each HBO treatment is similar to sitting in an aircraft while it descends. Like the airline passenger, the patient’s ears have to adjust to a change in air pressure. The hyperbaric health care professional works with the patient or parent and teaches them various techniques on how to equalize pressure in the ears, such as swallowing.

If one cannot equalize the pressure in the ears, damage can occur to the eardrum. However, this is very rare. Some individuals who experience ear discomfort may require a procedure called a Myringotomy, or what is commonly called placing tubes in the ears. An ear, nose and throat specialist usually performs this outpatient procedure right in the doctor’s office.

Other complications can occur if a patient has lung abnormalities such as emphysema. However, with proper evaluation prior to HBO treatment any concerns can be eliminated.

A Promising Therapy

Why does HBO therapy show promise in helping Lyme patients? First, we are reminded that Lyme bacteria are microaerophilic, or debilitated in high oxygen environments. Research by F. Austin demonstrated the effect of oxygen on the Lyme organism. The study suggests that the Bb organism is sensitive to high concentrations of oxygen at the cellular level, or what is termed,

elevated tissue partial pressures. In other words, the Bb organism doesn’t do well in a biological environment similar to that created in the body during HBO treatment.

Once it was clinically determined that Lyme bacteria may be adversely affected by the conditions created in the body during HBO therapy, the next step was to conduct a more in-depth study. One such subjective study was completed in 1997 by William Fife, Ph. D. at the Texas A & M Hyperbaric Laboratory and approved by the Texas A & M University Review Board.

The results of the study were significant: improvement in approximately 85 percent of the 66 patients treated. Improvement is defined as a decrease or the elimination of symptoms. (See the outline of Dr. Fife’s study, Effects of Hyperbaric Oxygen Therapy on Lyme Disease under the treatment section at http://www.hbotoday.com./.)

It is also notable that all of the study’s participants were veterans of antibiotic therapy. These were adults and children who had tried and failed antibiotic therapy, including the big gun in the antibiotic arsenal: intravenous antibiotics. It appeared that the study had chosen the most difficult subjects to test. These were Lyme patients with chronic symptoms and most of them probably had nothing to lose. The fact that 85 percent of these Lyme patients showed improvement seems remarkable.

Other Benefits of HBO Therapy

There are other benefits of HBO therapy that may play a role in treating Lyme disease, but were not mentioned in the Texas A & M study. Some of these benefits are theoretical and not proven; others are well known and considered established fact in Hyperbaric Medicine. Many of these additional benefits are based on the belief that HBO therapy and antibiotic therapy work in a synergistic manner. In this context, synergistic is defined as the combination of both treatments (HBO therapy and antibiotic therapy) being greater than the effect of either one alone. First, let’s review.

Earlier we discussed how antibiotics and the immune system might not be able to adversely affect (or kill) Lyme bacteria for two distinct reasons. First, it is believed that the Bb organism is able to switch from an active to a dormant (or sleeping mode) by coating itself in the body’s protein. It is also believed that the Bb organism can hide in the body’s cells. Both tactics may result in the immune system failing to react to the Bb organism as a foreign organism that should be destroyed. Some believe that this has the effect of neutralizing the body’s defensive mechanisms and the offensive mechanisms employed by antibiotics.

Complicated Therapy

Lyme physicians take all of this relatively new knowledge about bacterial biology into account when deciding which antibiotic, or combination of antibiotics to prescribe. The above scenario suggests that, depending upon dosage, some classes of antibiotics such as penicillins and cephalosporins may not be able to eradicate Lyme bacteria from the body because they circulate mainly in the body’s fluids and are incapable of entering cells where the Bb organism can reside. If true, this contradicts many current conservative antibiotic protocols for Lyme disease.

The good news is that other classes of antibiotics, such as macrolides (azithromycins such as Zithromax) are prescribed specifically to attack the Bb bacteria that may become established within the body’s cells, along with killing Lyme bacteria residing outside the cells in deep tissue areas of the body.

It is important to recognize that this is a case in point where a shotgun approach to antibiotic therapy may be an effective tool in fighting Lyme disease. For example, a physician may prescribe a penicillin such as Amoxicillin, along with a macrolide such as Zithromax. The Amoxicillin stays mostly in the body’s fluids and blood stream. Meanwhile, Zithromax not only penetrates the cell wall where the Bb organism is residing (and/or hiding), but it also penetrates deep tissue areas, which Lyme bacteria also inhabit. When Lyme bacteria move to deep tissue areas they have effectively moved away from normal blood flow and away from fluid-based antibiotics. Antibiotics such as Zithromax can help to counter this survival tactic.

Also, Amoxicillin is mainly bactericidal (remember, think… homicidal), which means that it directly kills the Bb organism. Zithromax is a macrolide, which means that it can either be bactericidal or bacteriostatic (think… manipulative) depending upon concentration levels. By prescribing these two antibiotics, physicians hope to increase the opportunities for killing as many bacteria as possible, and affecting Lyme bacteria in numerous and complex ways.

Obviously, physicians prescribe many other combinations of antibiotics to combat the Bb organism.

Even though physicians can out-maneuver some of the Lyme bacterium’s survival tactics—such as using combinations of antibiotics—there are those who believe that antibiotics probably cannot eliminate the Bb organism if it is in a dormant state. Again, if this is true, it has serious consequences for the diagnosis and treatment of chronic, persistent symptoms. Specifically, this means that conservative treatment protocols, which call for short-term courses of antibiotics, may actually prolong some cases of Lyme infection. If chronic Lyme symptoms are the result of an active, late-stage Lyme infection, any delay in full and comprehensive antibiotic treatment may have devastating results for the Lyme patient.

Adding HBO Therapy

Now we add HBO therapy to the mix. We previously stated that Dr. Fife’s study suggests that the Bb organism is sensitive to elevated levels of oxygen at the cellular level. This is an environment similar to that created in the body during HBO therapy. Unfortunately, at this time we do not know much about HBO’s effect on dormant Lyme bacteria. However, Fife’s study conclusively showed that HBO therapy does have a significant and positive impact on a high percentage of Lyme patients who failed antibiotic therapy. The exact reasons why this is so are not clear.

It is interesting to note that some believe that HBO therapy can kill the Bb organism directly. This begs the question, “Can HBO therapy directly kill the Bb organism on its own?” It seems possible that the answer to this question may be yes. A positive response seems reasonable because Lyme patients who have undergone HBO therapy without taking antibiotics seem to have experienced a Herxheimer reaction during treatment. This suggests that HBO therapy alone was responsible for the bacteria die-off. If true, HBO therapy would indeed be capable of killing the Bb organism directly. Again, more research would be helpful.

Angiogenesis Plays a Role

HBO therapy facilitates angiogenesis. Angiogenesis is defined as the development of blood vessels in the body. This may become important in the treatment of Lyme disease because it is believed that Lyme bacteria effectively evade antibiotics by moving away from normal blood flow into tissue, organs and bone. Thus, the farther that the antibiotic can move into these areas through a more dense and extensive system of blood vessels, the greater the opportunity to kill the Bb organism. HBO therapy’s facilitation of angiogenesis allows the antibiotic to potentially have a greater effect on Lyme bacteria by helping to move the antibiotic closer to those parts of the body where the bacteria may be residing.

Bacterial Cell Wall Penetration

There is emerging evidence that certain antibiotics may be more readily incorporated into the cell wall of the bacteria itself in the presence of elevated oxygen tension, which is an environment similar to that created in the body during HBO therapy. If true, this is a clear example of HBO therapy working in a synergistic manner with antibiotic therapy. In other words, the effectiveness of antibiotics to kill the Lyme organism is increased through the use of HBO therapy.

Research is currently being conducted that may indicate that the Bb organism can be killed by oxygen free radicals. Oxygen free radicals are produced during HBO therapy. The deeper the depth of treatment, the greater the number of free radicals produced. It is believed by many that oxygen free radicals have an antibiotic-like effect.

Finally, it is well understood that HBO therapy can enhance certain aspects of the body’s natural immune system. This may play a significant and positive role for Lyme patients because their immune systems have probably been compromised over a long period of time as a result of persistent symptoms.

Further Research

The benefits of HBO therapy appear to be far reaching, as well as having particular significance for Lyme patients. However, further research would be helpful in establishing better diagnostic testing procedures for Lyme disease and precise protocols of treatment for HBO therapy. The former obviously includes a precise test to directly measure the presence of Lyme bacteria in the body, or absence thereof. The latter includes the ideal total number of HBO treatments (and their depth) necessary to treat Lyme disease.

It would also be helpful to better understand the exact mechanism of action that occurs in HBO therapy. After all, Dr. Fife’s study showed improvement in 85 percent of the 66 patients who were monitored during his Lyme disease/HBO therapy research study. Simply, it would be helpful to understand precisely why so many Lyme patients got better.

In general, a better understanding of the Lyme bacterium will enable us to develop new and better methods of treating this devastating disease.

In Conclusion

This article has attempted to use current scientific knowledge to inquire into, and to speculate on possible explanations of why HBO therapy is helpful for some Lyme patients. As we stated earlier, just as the diagnosis and treatment of Lyme disease is “subjective, open to discussion, individualized, and often complex,” we acknowledge that this article has been subjective and it should be open to question. However, we also feel that no stone should be left unturned in society’s effort to understand a disease that has done the following three things:

o Devastated so many individual lives. o Strongly impacted so many families. o Afflicts an untold number of people around the world.

We know that antibiotic therapy helps some people who suffer from Lyme disease. We don’t fully know why this is so. We also know that HBO therapy helps some people who suffer from Lyme disease. Again, we don’t fully know why this occurs. In both cases we feel that it is important to learn why each of these treatments work for some people and not for others.

However, we believe that the major focus of medical science should be on developing an accurate test for Lyme disease. Such a test will do more to eliminate the current controversy and confusing protocols surrounding the diagnosis and treatment of Lyme disease than anything else will. Clarifying better ways of diagnosing and treating Lyme disease through more accurate testing methods will go a long way toward relieving the suffering that many Lyme patients continue to endure.

This article is Copyright © 1999 by the Chico Hyperbaric Center (HBOToday.com). Permission is given to reproduce it, in its entirety, and including this notice.